Michael Linenberger, Program Director
Fellows in our program train in state-of-the-art facilities with distinguished faculty who perform cutting-edge research to advance our knowledge of cancer and diseases of the blood, and translate these discoveries to clinical care of patients. Equally important, our trainees find a culture that is friendly, nurturing, stimulating and challenging with a love for learning that reflects the dedication and mission of the University of Washington and Fred Hutch.
The fellow’s experience in our program is rooted in comprehensive inpatient and outpatient clinical training and development of teaching skills, particularly during fulltime rotations over the course of 12 months (for single-boards eligibility) or 18 months (for dual-boards eligibility).
Continuity and disease-focused outpatient clinics provide graduated responsibilities in the management of patients with a broad range of disorders, including hematologic malignancies, classical hematology, blood and marrow transplantation (BMT), and solid tumor oncology. Enhanced experiences in transfusion medicine, cellular therapy, hemostasis/thrombosis and bone marrow failure are available through specialized tracks in the Hematology Focused Fellowship Training Program pathway.
Each fellow participates in a scholarly project with research training available in laboratory based, translational, clinical and epidemiologic arenas.
Fellows are always welcome at the many conferences and didactic sessions offered across the broad and diverse community at the University of Washington and Fred Hutch. However, the Core Curriculum Conference, Fellows Hematology Conference, and the Solid Tumor Conference are specifically conducted to enhance the education of our hematology-oncology fellows. Conferences bolster the clinical education experience for the junior fellows and aids in board review for the senior fellows.
A robust series of didactic lectures bolsters the clinical education experience for the junior fellows, and aids in board review for the senior fellows. Funded by the T32 training grant, fellows work closely with their research mentors and faculty advisors to acquire and refine their investigative skills in a specific discipline that will become the foundation for a career-sustaining area of focus and expertise.
Core Curriculum Conference Series
The Fellows' Core Curriculum Conference Series is held year-round on Friday from 7-8am at the Fred Hutchinson Cancer Research Center. Attendance is required, and fellows are excused from clinical duties to attend. Faculty, representing a wide variety of hematology-oncology fields, provide the content and deliver the lectures. Michael Linenberger, M.D., F.A.C.P. and William Harris, M.D. oversee the planning of this core lecture series in accordance with ACGME requirements for core objectives.
Fellows’ Hematology Conference
The Fellows' Hematology Conference is held on the second and fourth Friday of the month right after the Core Curriculum Conference lecture. The goal of this conference is for the fellow to develop the skills needed to assimilate a body of information related to a hematology-related issue of their choice, synthesize this information, and effectively convey what they have learned to an interested audience. Jill Johnsen, MD is the faculty sponsor.
Solid Tumor Conference
The Solid Tumor Conference (STC) is a fellow-led forum held between noon and 1pm (lunch provided). The goal of the conference is to incorporate faculty guidance and discussion about the management of solid tumor cancers and potential applications of emerging research and hot topics. The conference is chaired this year by Poorni Manohar and Ali Khaki. Hannah Linden, M.D. serves as the faculty sponsor. All research fellows and available clinical fellows are expected to attend
Our major focus is the preparation of fellows for burgeoning academic careers in basic science, translational research, clinical research and specialty areas such as global health and comparative effectiveness research. Clinical training is supported by participating hospitals. The full-time research phase of our program is funded by T32 training grants from the National Cancer Institute and National Heart Lung and Blood Institute. Post-fellowship funding opportunities include a variety of institutional and other private sources. K-12 institutional grant support is also available through the Hematology and Medical Oncology divisions. The Institute for Translational Health Sciences (ITHS) at UW offers didactic coursework, certificate and degree programs for fellows interested in careers in clinical and translational research. Many of these funding mechanisms can extend into early junior faculty years.